Placental Lactogen
Placental Hormones
Placenta
Prolactin
Growth Hormone
Pregnancy
Pregnancy-Specific beta 1-Glycoproteins
Receptors, Prolactin
Pregnancy, Animal
Trophoblasts
Estriol
Abortion, Threatened
Sheep
Choriocarcinoma
Placental Extracts
Animal Nutrition Sciences
Radioligand Assay
Butoxamine
Radioimmunoassay
Pregnancy Proteins
Receptors, Somatotropin
Chorionic Gonadotropin
Progesterone
Receptors, Peptide
Adrenergic beta-2 Receptor Antagonists
Pregnancy Trimester, Third
Difference between mammary epithelial cells from mature virgin and primiparous mice. (1/349)
Mammary epithelial cells from mature virgin mice are similar to those from primiparous mice in several respects. However, there is one known difference. The cells from the mature virgin must traverse the cell cycle in order to become competent to make casein and enzymatically active alpha-lactalbumin in vitro; those from the primiparous animal can make these proteins without first traversing the cycle. In this regard, cells from human placental lactogen- and prolactin-treated mature virgins are, after involution, similar to those from primiparous mice. The developemental block in the cells from the mature virgin, imposed by preventing cell cycle traversal, has been partially delineated. It does not appear to reside at the levels of ultrastructural maturation or the formation of casein messenger RNA. Rather, the lesion is postranscriptional and may be at the level of translation, or posttranslational modification, or both. (+info)Ruminant placental lactogens act as antagonists to homologous growth hormone receptors and as agonists to human or rabbit growth hormone receptors. (2/349)
Growth hormone receptor (GHR)-mediated activity of ruminant placental lactogens (PLs) and ovine (o) GH was compared, using cells transfected with full size human (h), rabbit (rb), and oGHRs. All three PLs acted as agonists in heterologous bioassays, whereas in homologous bioassays in cells transfected with oGHRs they antagonized the oGH activity. Despite these differences, oGH and PLs bound with similar affinity to the oGHR extracellular domain (oGHR-ECD), indicating that the binding occurs through hormone site I. Gel filtration of complexes between oPL and oGHR-ECD showed a 1:1 stoichiometry, confirming this conclusion. The oPL T185D and bPL T188D, which exhibited weak biological activity mediated through GHRs, behaved as site I antagonists, whereas oPL G130R and bPL G133R formed a 1:1 complex with GHR-ECDs and bound to h/rb/oGHR-ECDs with affinity similar to that of wild-type oPL. They had no agonistic activity in all models transfected with h/rb and oGHRs, but were antagonistic to all of them. In conclusion, ruminant PLs antagonize the activity of oGH in homologous systems, because they cannot homodimerize oGHRs, whereas in heterologous systems they act as agonists. The structural analysis hints that minor differences in the sequence of the GHR-ECDs may account for this difference. Since the initial step in the activity transduced through cytokine/hemapoietic receptors family is receptor homodimerization or heterodimerization, we suggest that the question of homologous versus heterologous interactions should be reexamined. (+info)Demonstration of in vivo mammogenic and lactogenic effects of recombinant ovine placental lactogen and mammogenic effect of recombinant ovine GH in ewes during artificial induction of lactation. (3/349)
The present study demonstrates that ovine placental lactogen (oPL) (ovine chorionic somatotrophin) may have an important role in the mammogenesis and/or lactogenesis of the ewe. Its effects were compared with that already described for ovine growth hormone (oGH). In the first experiment, 40 nulliparous ewes were induced to lactate by means of a 7 day (days 1-7) oestro-progestative treatment (E2+P4). The ewes from Group 1 (n=12) received no further treatment, while those of the other groups received either recombinant oGH (roGH, 28 micrograms/kg, i.m., twice daily, Group 2, n=12) or recombinant oPL (roPL, 79 micrograms/kg, i.m., twice daily, Group 3, n=12) from day 11 to 20. All ewes received 25 mg hydrocortisone acetate (HC) twice daily on days 18-20. Control Group 00 (n=2) received no steroid treatment at all, and the control Group 0 (n=2) received only the E2+P4 treatment. Thirteen ewes (three from each experimental group and the two of each control group) were slaughtered at the end of hormone treatments (day 21) before any milking stimulus. The 27 remaining ewes from Groups 1-3 were machine-milked and milk yields recorded daily from day 21 to 76. The E2+P4 treatment enhanced the plasma levels of oPRL, oGH and IGF-I between days 1 and 7 by 1.5, 2. 3 and 2.6 times respectively (P=0.002); roGH treatment induced a highly significant enhancement of IGF-I plasma levels from day 11 to 20, whereas a similar effect appeared for roPL-treated ewes only from day 17 to 20 (P<0.01). Eight weeks after the last exogenous hormone injections, milk yields of both roGH- and roPL-treated groups progressively rose to twice that of unsupplemented groups (P<0.001). The mammary DNA content on day 21 was higher for animals which received either oGH or oPL but, due to individual variations in so few samples (n=3), this difference was not significant. No beta-casein was measured in mammary tissue from control ewes, whereas steroid-treated ewes (E2+P4+HC) had higher casein concentrations regardless of subsequent hormonal treatment on days 11-20 (P<0.001). beta-Casein concentrations in mammary parenchyma of roGH-treated ewes did not differ from that of ewes which received only E2+P4+HC; roPL supplementation clearly enhanced expression of beta-casein (P<0.001). IGF-I stimulation by either roGH or roPL was more precisely examined during a second experiment, in which two twice-daily i.m. doses (58 or 116 micrograms/kg) of either roGH or roPL were administered to four groups of six ewes that were E2+P4 treated as those of Experiment 1. A control group (n=6) received no exogenous hormone from day 11 to 13. On day 13, hourly blood samples were taken from all ewes over 11 h. Both doses of roGH significantly stimulated IGF-I in a dose-dependent manner. The 58 micrograms/kg dose of roPL did not significantly stimulate IGF-I, but although being somewhat less efficient than the 58 micrograms/kg dose of roGH, the 116 micrograms/kg dose of roPL significantly stimulated IGF-I secretion (P<0. 001). These results suggest that mammogenesis and/or lactogenesis in the ewe is in part controlled by somatotrophic hormones such as oGH and oPL and that IGF-I could be one of the mediators of these hormones. (+info)The purification and characterization of rabbit placental lactogen. (4/349)
Rabbit placental lactogen, a polypeptide hormone functionally related to the growth hormone/prolactin family, was isolated from placenta by (NH4)2SO4 precipitation, gel filtration and ion-exchange chromatography on DEAE-and CM-cellulose. The hormone was purified to more than 90% homogeneity, as determined by end-group analysis. On disc gel electrophoresis at pH9.0 it migrates as a pair of closely spaced bands with mobilities of 0.489 (minor band) and 0.511 (major band), and its isoelectric point is 6.1. Its mol.wt. is 20600, as determined by sedimentation--equilibrium centrifugation, and 24200, as estimated by gel electrophoresis in sodium dodecyl sulphate. Its amino acid composition resembles that of rabbit growth hormone and rat prolactin, except for a lower glutamic acid and leucine content. Like the prolactins, rabbit placental lactogen has two tryptophan and six cysteine residues, and its N-terminus, valine, is identical with that for human placental lactogen. By radioimmunoassay, it does not cross-react with antisera to either rat growth hormone or rat prolactin; in addition, it does not cross-react with antisera to bovine placental lactogen by double immunodiffusion. The similarity of the biochemical characteristics of rabbit placental lactogen to the other non-primate placental lactogens lends further support to the hypothesis that these molecules occupy a more central position in the growth hormone/prolactin "tree" than do their primate counterparts. (+info)Ovine chorionic somatomammotrophin (oCS) production by isolated cotyledon cells from sheep in early and mid gestation: auto-regulation by recombinant oCS. (5/349)
We report the ability of sheep placental cotyledonary cells, isolated at different periods of pregnancy (40 to 90 days) to produce ovine chorionic somatomammotrophin (oCS) in in vitro culture conditions. This oCS production increased gradually with stage of pregnancy. Endogenous oCS net production by isolated placental cells was increased, in a dose-dependent manner, by addition of recombinant oCS (roCS). This effect was not observed after addition of recombinant ovine growth hormone. The roCS effect was more potent on cells collected during early pregnancy. Specific immunoprecipitation of oCS revealed that roCS treatment was associated with an increased dose-dependent incorporation of [35S]methionine-[35S]cysteine. These findings provide evidence that oCS may act in a paracrine/autocrine manner to up-regulate its own production during early gestation. We suggest that this autoregulation may be associated with morphological and functional differentiation of the trophoblast during the growth of the placenta. (+info)Enzyme-linked immunosorbent choriomammotropin assay. (6/349)
We have devloped an enzyme-linked immunosorbent assay for determining choriomammotropin (human placental lactogen) in serum. Unlabeled hormone competes with choriomammotropin-beta-galactosidase conjugate for antibody bound to polystyrene tubes. The entire assay can be performed in 2.5 h with good precision. The coefficient of variation for one sample with a mean concentration of 5.6 mg/L, assayed 10 times on the same day, was 5.7%. The coefficient of variation for nine samples (3.5 to 9.0 mg/L) assayed on five different days was 7.9%. Forty-eight clinical samples were assayed (y) and compared with results obtained by radial immunodiffusion (x). The resulting regression equation was: y = 1.05x + 0.78; r = 0.91. (+info)Functional domains of human growth hormone necessary for the adipogenic activity of hGH/hPL chimeric molecules. (7/349)
Genetic analysis through construction of chimeric genes and their transfection in mammalian cells could provide a better understanding of biological functions of native or modified proteins, and would allow the design of new gene constructs encoding peptides that mimic or block ligand interaction with target tissues. To identify the hGH domains responsible for induction of adipose differentiation we constructed hGH/hPL chimeric molecules using homologous DNA mutagenesis, since hGH, but not human placental lactogen (hPL), promotes adipose differentiation in mouse 3T3-F442A cells. We assayed their adipogenic activity in an autocrine/paracrine biological model consisting of transiently transfected 3T3-F442A cells with the chimeric constructs. Plasmid DNAs carrying these constructs were transfected into growing 3T3-F442A cells, and cultures were further maintained for 7 days to differentiate into adipocytes. Secretion of transfected hGH/hPL chimeric proteins into the medium was in the range of 5-25 ng/ml. Adipogenic activity was a property only of those chimeric proteins that contained hGH exon III together with either hGH exon II or hGH IV. Our results also suggest that hGH binding site-2 is composed of two structural subdomains: subsite 2A encoded by exon II of hGH and subsite-2B encoded by exon IV. We also suggest that full adipogenic activity requires the presence of binding site-1 and any of the subsites of binding site-2. This simple autocrine/paracrine biological model of gene transfection allows the analysis of specific biological activity of products encoded by modified genes. (+info)Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency. (8/349)
Pregnant ewes were exposed chronically to thermoneutral (TN; 20+/-2 degrees C, 30% relative humidity; n=8) or hyperthermic (HT; 40+/-2 degrees C 12 h/day, 35+/-2 degrees C 12 h/day, 30% relative humidity, n=6) environments between days 37 and 93 of pregnancy. Ewes were killed following 56 days of exposure to either environment (days in treatment (dit)), corresponding to 93+/-1 day post coitus (dpc). Maternal core body temperatures (CBT) in HT ewes were significantly elevated above the TN ewes (HT; 39.86+/-0.1 degrees C vs TN; 39.20+/-0.1 degrees C; P<0.001). Both groups of animals displayed circadian CBT, though HT ewes had elevated amplitudes (HT; 0.181+/-0.002 degrees C vs TN; 0.091+/-0.002 degrees C; P<0.001) and increased phase shift constants (HT; 2100 h vs TN; 1800 h; P<0.001). Ewes exposed to chronic heat stress had significantly reduced progesterone and ovine placental lactogen (oPL) concentrations from 72 and 62 dpc respectively (P<0.05), corresponding to approximately 30 dit. However, when compared with the TN ewes, HT cotyledonary tissue oPL mRNA and protein concentrations were not significantly different (P>0.1). Prolactin concentrations rose immediately upon entry into the HT environment, reaching concentrations approximately four times that of TN ewes, a level maintained throughout the study (HT; 216.31+/-32.82 vs TN; 54. 40+/-10.0; P<0.0001). Despite similar feed intakes and euglycemia in both groups of ewes, HT fetal body weights were significantly reduced when compared with TN fetuses (HT; 514.6+/-48.7 vs TN; 703. 4+/-44.8; P<0.05), while placental weights (HT; 363.6+/-63.3 vs TN; 571.2+/-95.9) were not significantly affected by 56 days of heat exposure. Furthermore, the relationship between body weight and fetal length, the ponderal index, was significantly reduced in HT fetuses (HT; 3.01+/-0.13 vs TN; 3.57+/-0.18; P<0.05). HT fetal liver weights were also significantly reduced (HT; 27.31+/-4.73 vs TN; 45.16+/-6.16; P<0.05) and as a result, the brain/liver weight ratio was increased. This study demonstrates that chronic heat exposure lowers circulating placental hormone concentrations. The observation that PL mRNA and protein contents are similar across the two treatments, suggests that reduced hormone concentrations are the result of impaired trophoblast cell development, specifically trophoblast migration. Furthermore, the impact of heat exposure during maximal placental growth is great enough to restrict early fetal development, even before the fetal maximal growth phase (100 dpc-term). These data highlight that intrauterine growth retardation (IUGR) may result primarily from placental trophoblast cell dysfunction, and secondarily from later reduced placental size. (+info)Placental lactogen is a hormone produced by the placenta during pregnancy in humans and some other mammals. It is similar in structure to human growth hormone and prolactin, and has both growth-promoting and lactogenic (milk-producing) properties. Placental lactogen plays an important role in regulating maternal metabolism during pregnancy, promoting the growth and development of the fetus, and preparing the mother's body for lactation after birth. It helps to stimulate the growth of the mammary glands and the production of milk by increasing the availability of nutrients such as glucose, amino acids, and fatty acids in the mother's bloodstream. Placental lactogen also helps to regulate the mother's insulin sensitivity, which can affect her energy levels and the growth of the fetus.
Placental hormones are a type of hormones that are produced by the placenta, an organ that develops in the uterus during pregnancy. These hormones play a crucial role in maintaining and supporting a healthy pregnancy. Some of the key placental hormones include:
1. Human Chorionic Gonadotropin (hCG): This hormone is produced after implantation and is detected in the urine or blood to confirm pregnancy. It maintains the corpus luteum, which produces progesterone during early pregnancy.
2. Progesterone: This hormone is critical for preparing the uterus for pregnancy and maintaining the pregnancy. It suppresses maternal immune response to prevent rejection of the developing embryo/fetus.
3. Estrogen: This hormone plays a vital role in the growth and development of the fetal brain, as well as promoting the growth of the uterus and mammary glands during pregnancy.
4. Human Placental Lactogen (hPL): This hormone stimulates maternal metabolism to provide nutrients for the developing fetus and helps prepare the breasts for lactation.
5. Relaxin: This hormone relaxes the pelvic ligaments and softens and widens the cervix in preparation for childbirth.
These hormones work together to support fetal growth, maintain pregnancy, and prepare the mother's body for childbirth and lactation.
The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the growing baby through the umbilical cord. It also removes waste products from the baby's blood. The placenta attaches to the wall of the uterus, and the baby's side of the placenta contains many tiny blood vessels that connect to the baby's circulatory system. This allows for the exchange of oxygen, nutrients, and waste between the mother's and baby's blood. After the baby is born, the placenta is usually expelled from the uterus in a process called afterbirth.
Prolactin is a hormone produced by the pituitary gland, a small gland located at the base of the brain. Its primary function is to stimulate milk production in women after childbirth, a process known as lactation. However, prolactin also plays other roles in the body, including regulating immune responses, metabolism, and behavior. In men, prolactin helps maintain the sexual glands and contributes to paternal behaviors.
Prolactin levels are usually low in both men and non-pregnant women but increase significantly during pregnancy and after childbirth. Various factors can affect prolactin levels, including stress, sleep, exercise, and certain medications. High prolactin levels can lead to medical conditions such as amenorrhea (absence of menstruation), galactorrhea (spontaneous milk production not related to childbirth), infertility, and reduced sexual desire in both men and women.
Growth Hormone (GH), also known as somatotropin, is a peptide hormone secreted by the somatotroph cells in the anterior pituitary gland. It plays a crucial role in regulating growth, cell reproduction, and regeneration by stimulating the production of another hormone called insulin-like growth factor 1 (IGF-1) in the liver and other tissues. GH also has important metabolic functions, such as increasing glucose levels, enhancing protein synthesis, and reducing fat storage. Its secretion is regulated by two hypothalamic hormones: growth hormone-releasing hormone (GHRH), which stimulates its release, and somatostatin (SRIF), which inhibits its release. Abnormal levels of GH can lead to various medical conditions, such as dwarfism or gigantism if there are deficiencies or excesses, respectively.
Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.
Pregnancy-specific beta-1 glycoproteins (PSBGs), also known as SP1 or SP-1, are a group of proteins that are produced in large quantities by the placenta during pregnancy. They were first discovered in 1974 and are found in the serum of pregnant women. These proteins belong to the immunoglobulin superfamily and are involved in various physiological processes during pregnancy, such as implantation, placentation, and fetal development.
PSBGs have been identified as potential markers for early pregnancy diagnosis, as their levels start to rise shortly after conception and can be detected in the maternal bloodstream within days of implantation. They also play a role in the regulation of immune responses during pregnancy, helping to prevent the mother's immune system from attacking the developing fetus.
There are several isoforms of PSBGs, including PSBG1, PSBG2, and PSBG3, which differ in their molecular weight and other biochemical properties. The function of these different isoforms is not fully understood, but they may have distinct roles in the regulation of pregnancy-related processes.
It's worth noting that while PSBGs are produced during pregnancy, they can also be found in non-pregnant individuals, albeit at much lower levels. The exact role of PSBGs outside of pregnancy is not well understood and requires further research.
Prolactin receptors are proteins found on the surface of various cells throughout the body that bind to the hormone prolactin. Once prolactin binds to its receptor, it activates a series of intracellular signaling pathways that regulate diverse physiological functions, including lactation, growth and development, metabolism, immune function, and behavior.
Prolactin receptors belong to the class I cytokine receptor family and are expressed in many tissues, including the mammary gland, pituitary gland, liver, kidney, adipose tissue, brain, and immune cells. In the mammary gland, prolactin signaling through its receptor is essential for milk production and breast development during pregnancy and lactation.
Abnormalities in prolactin receptor function have been implicated in several diseases, including cancer, infertility, and metabolic disorders. Therefore, understanding the structure, regulation, and function of prolactin receptors is crucial for developing new therapies to treat these conditions.
"Animal pregnancy" is not a term that is typically used in medical definitions. However, in biological terms, animal pregnancy refers to the condition where a fertilized egg (or eggs) implants and develops inside the reproductive tract of a female animal, leading to the birth of offspring (live young).
The specific details of animal pregnancy can vary widely between different species, with some animals exhibiting phenomena such as placental development, gestation periods, and hormonal changes that are similar to human pregnancy, while others may have very different reproductive strategies.
It's worth noting that the study of animal pregnancy and reproduction is an important area of biological research, as it can provide insights into fundamental mechanisms of embryonic development, genetics, and evolution.
Trophoblasts are specialized cells that make up the outer layer of a blastocyst, which is a hollow ball of cells that forms in the earliest stages of embryonic development. In humans, this process occurs about 5-6 days after fertilization. The blastocyst consists of an inner cell mass (which will eventually become the embryo) and an outer layer of trophoblasts.
Trophoblasts play a crucial role in implantation, which is the process by which the blastocyst attaches to and invades the lining of the uterus. Once implanted, the trophoblasts differentiate into two main layers: the cytotrophoblasts (which are closer to the inner cell mass) and the syncytiotrophoblasts (which form a multinucleated layer that is in direct contact with the maternal tissues).
The cytotrophoblasts proliferate and fuse to form the syncytiotrophoblasts, which have several important functions. They secrete enzymes that help to degrade and remodel the extracellular matrix of the uterine lining, allowing the blastocyst to implant more deeply. They also form a barrier between the maternal and fetal tissues, helping to protect the developing embryo from the mother's immune system.
Additionally, trophoblasts are responsible for the formation of the placenta, which provides nutrients and oxygen to the developing fetus and removes waste products. The syncytiotrophoblasts in particular play a key role in this process by secreting hormones such as human chorionic gonadotropin (hCG), which helps to maintain pregnancy, and by forming blood vessels that allow for the exchange of nutrients and waste between the mother and fetus.
Abnormalities in trophoblast development or function can lead to a variety of pregnancy-related complications, including preeclampsia, intrauterine growth restriction, and gestational trophoblastic diseases such as hydatidiform moles and choriocarcinomas.
Estriol is a type of estrogen, which is a female sex hormone. It is produced in the placenta during pregnancy and is used as a marker for fetal growth and development. Estriol levels can be measured in the mother's urine or blood to assess fetal well-being during pregnancy. Additionally, synthetic forms of estriol are sometimes used in hormone replacement therapy to treat symptoms of menopause.
A "threatened abortion" is a medical term used to describe a situation in which there are symptoms that suggest an impending miscarriage, such as vaginal bleeding and/or cramping during early pregnancy, but the cervix remains closed and the fetal heartbeat is still present. This condition is estimated to occur in up to 20-30% of all pregnancies, and while it can be a source of anxiety for pregnant individuals, it does not necessarily mean that a miscarriage will definitely occur.
It's important to note that if you are experiencing any symptoms of a threatened abortion, you should contact your healthcare provider right away for evaluation and guidance on how to manage the situation. They may recommend bed rest, pelvic rest, or other treatments to help support the pregnancy and reduce the risk of miscarriage.
I apologize, but "sheep" is not a term that has a medical definition. It is a common animal with the scientific name Ovis aries. If you have any medical or health-related questions, I would be happy to try and help answer those for you.
Choriocarcinoma is a rapidly growing and invasive type of gestational trophoblastic disease (GTD), which are abnormal growths that develop in the tissues that are supposed to become the placenta during pregnancy. It occurs when a malignant tumor develops from trophoblast cells, which are normally found in the developing embryo and help to form the placenta.
Choriocarcinoma can occur after any type of pregnancy, including normal pregnancies, molar pregnancies (a rare mass that forms inside the uterus after conception), or ectopic pregnancies (when a fertilized egg implants outside the uterus). It is characterized by the presence of both trophoblastic and cancerous cells, which can produce human chorionic gonadotropin (hCG) hormone.
Choriocarcinoma can spread quickly to other parts of the body, such as the lungs, liver, brain, or vagina, through the bloodstream. It is important to diagnose and treat choriocarcinoma early to prevent serious complications and improve the chances of a successful treatment outcome. Treatment typically involves surgery, chemotherapy, or radiation therapy.
Placental extracts are substances that are derived from the placenta, which is an organ that connects the developing fetus to the uterine wall during pregnancy. These extracts contain a variety of biologically active compounds, including hormones, growth factors, and nutrients, which can have potential therapeutic effects.
Placental extracts are typically obtained from either human or animal placentas through a process of extraction and purification. They may be used in various medical and cosmetic applications, although their effectiveness and safety are still a subject of ongoing research and debate. Some proponents claim that placental extracts can help to promote healing, reduce inflammation, and improve skin health, among other benefits. However, more rigorous scientific studies are needed to confirm these claims and establish the appropriate uses and dosages of placental extracts in medical practice.
Animal nutrition sciences is a field of study that focuses on the nutritional requirements, metabolism, and digestive processes of non-human animals. It involves the application of basic scientific principles to the practice of feeding animals in order to optimize their health, growth, reproduction, and performance. This may include the study of various nutrients such as proteins, carbohydrates, fats, vitamins, and minerals, as well as how they are absorbed, utilized, and excreted by different animal species. The field also encompasses the development and evaluation of animal feeds and feeding strategies, taking into account factors such as animal age, sex, weight, production stage, and environmental conditions. Overall, the goal of animal nutrition sciences is to promote sustainable and efficient animal agriculture while ensuring the health and well-being of animals.
A radioligand assay is a type of in vitro binding assay used in molecular biology and pharmacology to measure the affinity and quantity of a ligand (such as a drug or hormone) to its specific receptor. In this technique, a small amount of a radioactively labeled ligand, also known as a radioligand, is introduced to a sample containing the receptor of interest. The radioligand binds competitively with other unlabeled ligands present in the sample for the same binding site on the receptor. After allowing sufficient time for binding, the reaction is stopped, and the amount of bound radioligand is measured using a technique such as scintillation counting. The data obtained from this assay can be used to determine the dissociation constant (Kd) and maximum binding capacity (Bmax) of the receptor-ligand interaction, which are important parameters in understanding the pharmacological properties of drugs and other ligands.
Butoxamine is a pharmaceutical drug that acts as an antagonist or blocker for β2-adrenergic receptors. These receptors are found in various tissues throughout the body and play a role in mediating the effects of catecholamines such as adrenaline and noradrenaline.
Butoxamine is primarily used in research settings to study the functions of β2-adrenergic receptors and their signaling pathways. It has been used to investigate the role of these receptors in various physiological processes, including airway smooth muscle relaxation, lipolysis, and insulin secretion.
It is important to note that Butoxamine is not approved for use in humans as a therapeutic agent, and its use is restricted to research purposes only.
Radioimmunoassay (RIA) is a highly sensitive analytical technique used in clinical and research laboratories to measure concentrations of various substances, such as hormones, vitamins, drugs, or tumor markers, in biological samples like blood, urine, or tissues. The method relies on the specific interaction between an antibody and its corresponding antigen, combined with the use of radioisotopes to quantify the amount of bound antigen.
In a typical RIA procedure, a known quantity of a radiolabeled antigen (also called tracer) is added to a sample containing an unknown concentration of the same unlabeled antigen. The mixture is then incubated with a specific antibody that binds to the antigen. During the incubation period, the antibody forms complexes with both the radiolabeled and unlabeled antigens.
After the incubation, the unbound (free) radiolabeled antigen is separated from the antibody-antigen complexes, usually through a precipitation or separation step involving centrifugation, filtration, or chromatography. The amount of radioactivity in the pellet (containing the antibody-antigen complexes) is then measured using a gamma counter or other suitable radiation detection device.
The concentration of the unlabeled antigen in the sample can be determined by comparing the ratio of bound to free radiolabeled antigen in the sample to a standard curve generated from known concentrations of unlabeled antigen and their corresponding bound/free ratios. The higher the concentration of unlabeled antigen in the sample, the lower the amount of radiolabeled antigen that will bind to the antibody, resulting in a lower bound/free ratio.
Radioimmunoassays offer high sensitivity, specificity, and accuracy, making them valuable tools for detecting and quantifying low levels of various substances in biological samples. However, due to concerns about radiation safety and waste disposal, alternative non-isotopic immunoassay techniques like enzyme-linked immunosorbent assays (ELISAs) have become more popular in recent years.
"Pregnancy proteins" is not a standard medical term, but it may refer to specific proteins that are produced or have increased levels during pregnancy. Two common pregnancy-related proteins are:
1. Human Chorionic Gonadotropin (hCG): A hormone produced by the placenta shortly after fertilization. It is often detected in urine or blood tests to confirm pregnancy. Its primary function is to maintain the corpus luteum, which produces progesterone and estrogen during early pregnancy until the placenta takes over these functions.
2. Pregnancy-Specific beta-1 Glycoprotein (SP1): A protein produced by the placental trophoblasts during pregnancy. Its function is not well understood, but it may play a role in implantation, placentation, and protection against the mother's immune system. SP1 levels increase throughout pregnancy and are used as a marker for fetal growth and well-being.
These proteins have clinical significance in monitoring pregnancy progression, detecting potential complications, and diagnosing certain pregnancy-related conditions.
Somatotropin receptors are a type of cell surface receptor that binds to and gets activated by the hormone somatotropin, also known as growth hormone (GH). These receptors are found in many tissues throughout the body, including the liver, muscle, and fat. When somatotropin binds to its receptor, it activates a series of intracellular signaling pathways that regulate various physiological processes such as growth, metabolism, and cell reproduction.
Somatotropin receptors belong to the class I cytokine receptor family and are composed of two subunits, a homodimer of extracellular glycoproteins that bind to the hormone and an intracellular tyrosine kinase domain that activates downstream signaling pathways. Mutations in the somatotropin receptor gene can lead to growth disorders such as dwarfism or gigantism, depending on whether the mutation results in a decrease or increase in receptor activity.
Chorionic Gonadotropin (hCG) is a hormone that is produced during pregnancy. It is produced by the placenta after implantation of the fertilized egg in the uterus. The main function of hCG is to prevent the disintegration of the corpus luteum, which is a temporary endocrine structure that forms in the ovary after ovulation and produces progesterone during early pregnancy. Progesterone is essential for maintaining the lining of the uterus and supporting the pregnancy.
hCG can be detected in the blood or urine as early as 10 days after conception, and its levels continue to rise throughout the first trimester of pregnancy. In addition to its role in maintaining pregnancy, hCG is also used as a clinical marker for pregnancy and to monitor certain medical conditions such as gestational trophoblastic diseases.
Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.
During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.
In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.
Peptide receptors are a type of cell surface receptor that bind to peptide hormones and neurotransmitters. These receptors play crucial roles in various physiological processes, including regulation of appetite, pain perception, immune function, and cardiovascular homeostasis. Peptide receptors belong to the G protein-coupled receptor (GPCR) superfamily or the tyrosine kinase receptor family. Upon binding of a peptide ligand, these receptors activate intracellular signaling cascades that ultimately lead to changes in cell behavior and communication with other cells.
Peptide receptors can be classified into two main categories: metabotropic and ionotropic. Metabotropic peptide receptors are GPCRs, which activate intracellular signaling pathways through coupling with heterotrimeric G proteins. These receptors typically have seven transmembrane domains and undergo conformational changes upon ligand binding, leading to the activation of downstream effectors such as adenylyl cyclase, phospholipase C, or ion channels.
Ionotropic peptide receptors are ligand-gated ion channels that directly modulate ion fluxes across the cell membrane upon ligand binding. These receptors contain four or five subunits arranged around a central pore and undergo conformational changes to allow ion flow through the channel.
Examples of peptide receptors include:
1. Opioid receptors (μ, δ, κ) - bind endogenous opioid peptides such as enkephalins, endorphins, and dynorphins to modulate pain perception and reward processing.
2. Somatostatin receptors (SSTR1-5) - bind somatostatin and cortistatin to regulate hormone secretion, cell proliferation, and angiogenesis.
3. Neuropeptide Y receptors (Y1-Y5) - bind neuropeptide Y to modulate feeding behavior, energy metabolism, and cardiovascular function.
4. Calcitonin gene-related peptide receptor (CGRP-R) - binds calcitonin gene-related peptide to mediate vasodilation and neurogenic inflammation.
5. Bradykinin B2 receptor (B2R) - binds bradykinin to induce pain, inflammation, and vasodilation.
6. Vasoactive intestinal polypeptide receptors (VPAC1, VPAC2) - bind vasoactive intestinal peptide to regulate neurotransmission, hormone secretion, and smooth muscle contraction.
7. Oxytocin receptor (OXTR) - binds oxytocin to mediate social bonding, maternal behavior, and uterine contractions during childbirth.
8. Angiotensin II type 1 receptor (AT1R) - binds angiotensin II to regulate blood pressure, fluid balance, and cell growth.
Adrenergic beta-2 receptor antagonists, also known as beta-2 adrenergic blockers or beta-2 antagonists, are a class of medications that block the action of epinephrine (adrenaline) and other catecholamines at beta-2 adrenergic receptors. These receptors are found in various tissues throughout the body, including the lungs, blood vessels, and skeletal muscles.
Beta-2 adrenergic receptor antagonists are primarily used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). They work by relaxing the smooth muscle in the airways, which helps to reduce bronchoconstriction and improve breathing.
Some examples of beta-2 adrenergic receptor antagonists include:
* Butoxamine
* ICI 118,551
* Salbutamol (also a partial agonist)
* Terbutaline (also a partial agonist)
It's important to note that while these medications are called "antagonists," some of them can also act as partial agonists at beta-2 receptors, meaning they can both block the action of catecholamines and stimulate the receptor to some degree. This property can make them useful in certain clinical situations, such as during an asthma attack or preterm labor.
The third trimester of pregnancy is the final stage of pregnancy that lasts from week 29 until birth, which typically occurs around the 40th week. During this period, the fetus continues to grow and mature, gaining weight rapidly. The mother's body also prepares for childbirth by dilating the cervix and producing milk in preparation for breastfeeding. Regular prenatal care is crucial during this time to monitor the health of both the mother and the developing fetus, as well as to prepare for delivery.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
Placental lactogen - Wikipedia
Placental Lactogen Ab - ARX Sciences | Buffalo, NY
Human PL(Placental Lactogen) ELISA Kit - Theragen Bio
What is the role of human placental lactogen (hPL) in metabolic regulation? | Attempt My Exam
Ovine placental lactogen and ovine prolactin: Partial proteolysis and conformational stability<...
Gestational Trophoblastic Neoplasia: Practice Essentials, Background, Pathophysiology
IRON: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
South Africa Tumor Markers Testing Market High Growth Opportunities for Cancer Diagnostic Tests and Analyzers
U2 Ob - Et 17 Medical & Surgical Complications Of Pregnancy - ProProfs Quiz
Profile | University of Otago
Oral Iron Prophylaxis in Pregnancy: Not Too Little and Not Too Much!
Search Results
Complications of Diabetes Mellitus
Pregnancy following Radical Resection of Solid Pseudopapillary Tumor of the Pancreas
Pediatric Hypocalcemia: Practice Essentials, Background, Pathophysiology
BRS Endocrine Physiology Quiz: Trivia! - ProProfs Quiz
SMART: Pfam domain Hormone 1
Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain...
Samir Fouad Abdel Aziz, MD
New: JNE Special Issue on FASEB Growth Hormone/Prolactin Conference
Diabetes During Pregnancy
Management of Euglycemic Diabetic Ketoacidosis
PDF) Association between menstrual disturbances and habitual use of caffeine
Research identifies optimal screening threshold for gestational diabetes - Diabetic recipes, free diabetes magazine & more!
SelectedWorks - David Hill
SMART: FN3 domain annotation
US Patent for Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates Patent (Patent # 7,723,485 issued May 25,...
Prenatal Diethylstilbestrol Exposure and Risk of Breast Cancer | Cancer Epidemiology, Biomarkers & Prevention | American...
Luz Irene Pascual Mathey | IntechOpen
Prolactin5
- Placental lactogen I and II were identified as prolactin-like molecules that can bind to prolactin receptor with high affinity and mimic the actions of prolactin. (wikipedia.org)
- The high-resolution structure of ovine placental lactogen (oPL) and ovine prolactin (oPRL), not yet established in detail, was probed by limited proteolysis with the Glu-specific protease from Staphylococcus aureus V8. (illinois.edu)
- It is instead increased, as 1-hydroxylase is upregulated by PTH-related protein (PTHrP), prolactin, and placental lactogen. (medscape.com)
- It is believed to be caused by raised levels of human placental lactogen, cortisol, prolactin, estrogen, and progesterone. (diabetesdigest.com)
- MANN, P. E. Central lactogenic regulation of maternal behavior in rats: steroid dependence, hormone specificity, and behavioral potencies of rat prolactin and rat placental lactogen I. Endocrinology , v.138, n. 2, p. 756-763, 1997. (bvsalud.org)
Estrogen2
- In addition, estrogen stimulates placental development, and the body fails the functions it is required to function. (attemptmyexam.com)
- In late pregnancy, the hormones estrogen, cortisol, and human placental lactogen can block insulin. (brighamandwomens.org)
Hormones1
- Particular interest has been taken in the interactions of endocrine hormones, such as growth hormone, placental lactogen and insulin, with the paracrine expression of growth factors, and nutritional availability and utilization during early growth. (bepress.com)
ELISA Kit2
- Description: A sandwich ELISA kit for detection of Placental Lactogen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (therabio.org)
- Description: The Human Placental Lactogen ELISA kit is an enzyme immunoassay for measurement of human Placental Lactogen (hPL) in serum. (therabio.org)
Insulin2
- A study has been made of the pre-eclampsia syndrome to assess the immediate effectsof this condition on carbohydrate metabolism and to determine whether the immediate.alterations in blood pressure, renal function and carbohydrate metabolism do predispose to permanent changes in later life.Plasma levels of glucose, human placental lactogen, and immunoreactive insulin wereobserved in the fasting state and for sixty minutes after a glucose challenge. (soton.ac.uk)
- The patients.with severe pre-eclampsia were found to have significantly lower fasting plasma levels of glucose, human placental lactogen and immunoreactive insulin compared with mild preeclamptic and normal pregnant cases. (soton.ac.uk)
Antibody1
- Murine monoclonal IgG antibody to human Placental Lactogen (native and recombinant). (arxsciences.com)
Polypeptide1
- Placental lactogen, also called chorionic somatomammotropin, is a polypeptide placental hormone, part of the somatotropin family. (wikipedia.org)
Placenta1
- Vitamin Placenta pills are a special form of placenta pills composed of placental extract. (vitaminplacenta.com)
Chorionic gonadotropin1
- During the last months of pregnancy, pheromones produced by the fetus - human chorionic gonadotropin and human placental lactogen - play a role in maturing her lobules into fully cancer-resistant Type 4 lobules. (abortionbreastcancer.com)
Estradiol1
- In conclusion, estriprostilbene-mediated inhibition of tissue maturation and visit here synthesis and resorption resulted in a marked increase in the levels of hPL in rats that were subjected to estradiol, compared with that in rats not treated with estradiol.What is the role of human placental lactogen (hPL) in metabolic regulation? (attemptmyexam.com)
Human growth1
- These two PRL mAbs are selective for hPRL as they do not inhibit other hPRLR agonists such as human growth hormone or placental lactogen. (iasp-pain.org)
Pregnancy1
- OBJECTIVE - The objectives of the study were to determine whether the cell cycle transcription factor, FoxM1, is required for glucose homeostasis and β-cell mass expansion in maternal islets during pregnancy and whether FoxM1 is essential for placental lactogen (PL)-induced β-cell proliferation. (umn.edu)
Protein1
- Maternal serum concentrations of glycosylated (Sambucus nigra lectin-reactive) fibronectin, adiponectin, sex hormone-binding globulin, placental lactogen, and high-sensitivity C-reactive protein (CRP) were measured at 5-13 weeks of gestation in a case-control study of 90 pregnant women with subsequent development of GDM and in 92 control group participants. (elsevierpure.com)
Mammary1
- Placental lactogen I may be important in stimulating mammary cell proliferation and in stimulating some of the adaptations of the maternal lipid and carbohydrate metabolism. (wikipedia.org)
Metabolic3
- What is the role of human placental lactogen (hPL) in metabolic regulation? (attemptmyexam.com)
- Home - Can Someone Do Anatomy and Physiology Exam - What is the role of human placental lactogen (hPL) in metabolic regulation? (attemptmyexam.com)
- The purpose of this review is to discuss the use of hCAAT as a model system for reproductive management and to review current information about hPL toxicity, especially the role of endosteroids, with respect to the use of hCAAT in maternal care.What is the role of human placental lactogen (hPL) in metabolic regulation? (attemptmyexam.com)
Fetus1
- have a peek here a result of these developmental issues for primary mochulism, hPL has been transferred to other organs by placental transplants, including the fetus. (attemptmyexam.com)
Fetal1
- Hypoxic damage to the human placental myometrium, the first non-lactogenic organ in the body, leads to disruption of the intrauterine life cycle by hormone secretion, often called fetal growth restriction. (attemptmyexam.com)
Plasma2
- Description: A competitive ELISA for quantitative measurement of Human Placental Lactogen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. (therabio.org)
- Description: A competitive ELISA for quantitative measurement of Canine Placental Lactogen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. (therabio.org)
Levels2
- Human placental lactogen (hPL) has the largest effect on blood glucose levels in this patient. (proprofs.com)
- During the 2nd trimester, blood pressure (BP) usually drops (and pulse pressure widens), even though CO and renin and angiotensin levels increase, because uteroplacental circulation expands (the placental intervillous space develops) and systemic vascular resistance decreases. (msdmanuals.com)
Transfer3
- However, in some cases, hPL is transmissible to the liver by placental transfer, and this is in fact the case in such cases. (attemptmyexam.com)
- In the case of placental transfer, a combination of trans[hPL], hPL analogues (ex vivo) and transcytosis of short hairpin nucleic acid (hCAAT), which is a click to read model system for the transfer of hPL. (attemptmyexam.com)
- It has also been used to study placental transfer of highly purified non-dioxin-like polychlorinated biphenyls in BeWo cells. (sigmaaldrich.com)
Form1
- For information on the human form, see human placental lactogen. (wikipedia.org)
Progesterone1
- At the basis of its development exists a variety of changes occurring during physiological pregnancy, such as the launch of placental lactogen, organic results of estrogen and progesterone or metabolism of the creating fetus. (cancer-pain.org)
Fetal6
- 12. Placental lactogen in maternal serum as an index of fetal health. (nih.gov)
- Gestational trophoblastic neoplasms (GTN) are a group of neoplasms from fetal trophoblastic cells including choriocarcinoma (CC), epithelioid trophoblastic tumors (ETT), and placental site trophoblastic tumors (PSTT) [ 1 ]. (hindawi.com)
- Malaria parasitaemia was assessed in maternal peripheral and placental blood, fetal haemoglobin was measured in cord blood, and maternal HIV status was determined. (bmj.com)
- Causal factors that predispose to poor fetal growth include maternal nutrition, impaired placental function, maternal diseases, infections, and environment influences. (bmj.com)
- IGF2 is influenced by placental lactogen and may play a role in fetal development. (nih.gov)
- In addition to its role in providing precursors for placental estrogen formation, the fetal adrenal cortex may participate in the events that lead to the initiation of labor and to maturation of the fetal lungs. (medscape.com)
Hormone6
- Placental lactogen, also called chorionic somatomammotropin, is a polypeptide placental hormone, part of the somatotropin family. (wikipedia.org)
- Human placental lactogen (hPL) and growth hormone (hGH) are thought to be derived from a common ancestral gene and have similar nucleotide and amino acid sequences. (nih.gov)
- Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. (cdc.gov)
- Value of the determination of placental lactogen hormone in the surveillance of pathologic pregnancies]. (bvsalud.org)
- We conclude that proliferin is a placental hormone that is synthesized in certain mouse cell lines during active growth. (nih.gov)
- We conclude that proliferin is a placental hormone that is also associated with the growth of a number of mouse cell lines in culture. (nih.gov)
Maternal2
- Placental lactogen I may be important in stimulating mammary cell proliferation and in stimulating some of the adaptations of the maternal lipid and carbohydrate metabolism. (wikipedia.org)
- Causes can be intrinsic (to the fetus) or extrinsic (maternal or placental problems). (wikidoc.org)
Pregnancy6
- This Special Issue of the International Journal of Molecular Sciences aims at providing novel insights into the mechanisms of embryo implantation and placental development as well as at giving an overview of our current knowledge on the different signaling pathways regulating the early steps of implantation and placentation and on the pathological alterations which may impair the establishment of a physiological pregnancy. (mdpi.com)
- 1. Serum placental lactogen levels in patients with molar pregnancy and trophoblastic tumors. (nih.gov)
- 2. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy. (nih.gov)
- 5. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases]. (nih.gov)
- In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. (nih.gov)
- This placental RNA is about 1 kilobase in length, increases sharply between days 8 and 10 of pregnancy, and then gradually declines through day 18. (nih.gov)
Glycoprotein1
- Using an antiserum prepared against a synthetic proliferin fusion protein, we show that proliferin is secreted as a glycoprotein by minced placental tissue and that it differs from mouse placental lactogen. (nih.gov)
Gene2
Tissue3
- Gel mobility shift assays showed that the hPL enhancer interacted specifically with nuclear proteins from JEG-3 cells and placental tissue. (nih.gov)
- Placental protein(s) binding this region may be instrumental in tissue-specific activity of the hPL enhancer. (nih.gov)
- 9. In vitro biosynthesis of human placental lactogen (HPL) by chorionic tissue and the diagnostic value of HPL in trophoblastic disease. (nih.gov)
Choriocarcinoma1
- others are invasive mole (chorioadenoma destruens), choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). (medscape.com)
Hydatidiform mole1
- 7. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole. (nih.gov)
Glucose1
- Human placental lactogen (hPL) has the largest effect on blood glucose levels in this patient. (proprofs.com)
Blood1
- During the 2nd trimester, blood pressure (BP) usually drops (and pulse pressure widens), even though CO and renin and angiotensin levels increase, because uteroplacental circulation expands (the placental intervillous space develops) and systemic vascular resistance decreases. (msdmanuals.com)
Site1
- Within the 138-bp enhancer, a 22-bp region overlapping a TEF-1 binding site was shown to be protected from DNase I digestion by placental and HeLa nuclear extracts. (nih.gov)
Shown1
- Minced pla- centas secreted immunologically detectable proliferin, which is shown to differ from the previously identified murine placental lactogen (mPL) (3). (nih.gov)